CliffBio
small molecule

CYANOCOBALAMIN

CYANOCOBALAMIN

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameCYANOCOBALAMIN
Active ingredientCYANOCOBALAMIN
Strength0.5MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalJune 2023
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.